Skip to main content

WELLS FARGO & COMPANY/MN

Position in SYRE — Spyre Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in SYRE

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$1,675,011
-$1,024,936 QoQ
Shares Held
33,208
-59.7% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,293,435,833 across 390 Biotechnology names. SYRE ranks #73 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SYRE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,675,011 33,208
2025-12-31 $2,699,947 82,416
2025-09-30 $658,985 39,319
2025-06-30 $515,102 34,409
2025-03-31 $484,614 30,035
2024-12-31 $575,434 24,718
2024-09-30 $523,791 17,810
2024-06-30 $403,783 17,175
2024-03-31 $85,039 2,242
2023-12-31 $494 23
2023-09-30 $269 22